Adial Pharmaceuticals, Inc. Non Peo Neo Avg Total Comp Amt
Adial Pharmaceuticals, Inc. (ADIL) reported Non Peo Neo Avg Total Comp Amt of $464.41 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-08-24.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-08-24
| Period end | Non Peo Neo Avg Total Comp Amt 12 month | Non Peo Neo Avg Total Comp Amt 12 month as first filed |
|---|---|---|
| 2025-12-31 | $464.41K DEF 14A · filed 2026-08-24 | $424.64K PRE 14A · filed 2026-08-11 |
| 2024-12-31 | $352.31K DEF 14A · filed 2026-08-24 | |
| 2023-12-31 | $412.02K DEF 14A · filed 2026-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |